What is Cytotron Therapy?

Cytotron® is an advanced medical technology designed to address cancer, degenerative joint disorders without surgery, ionizing radiation, or harmful side effects. Using Rotational Field Quantum Magnetic Resonance- Fast Radio Burst (RFQMR) technology, it uses non-ionising radiofrequency waves and high instantaneous magnetic fields (Like in MRI) to influence abnormal cellular behavior while sparing healthy tissues.

Cytotron treatment in Bangalore using RFQMR technology

Scientific Foundations

The origins of RFQMR-FRB can be traced back to groundbreaking research conducted at the Centre for Advanced Research and Development (CARD) in 1987, where researchers investigated modulated radiofrequency fields within the 30 kHz–300 MHz spectrum. This research culminated in the development of multi-frequency, rotating electromagnetic fields that can influence cellular behavior—promoting regeneration in certain instances while inducing controlled degeneration in others. This pivotal discovery established the foundation for what is now known as Quantum Magnetic Resonance Therapy (QMRT®).

Regulatory Recognition & Clinical Validation

Cytotron has been in clinical use since 2004 and has reached numerous significant regulatory achievements worldwide. It obtained European CE certification in 2012 under the Medical Device Directive (MDD) for both cancer and musculoskeletal applications, with the transition from MDD to MDR currently underway, and it holds patents in the United States, European Union, and China. Compassionate-use studies conducted in Mexico City have confirmed its efficacy in treating various solid tumors, and specialized trials have also been carried out for pediatric brain cancers under the registration of the National Institutes of Health (NIH). In 2019, the U.S. Food and Drug Administration (FDA) awarded Breakthrough Device Designation to Cytotron for the treatment of breast, liver, and pancreatic cancers—underscoring its global acknowledgment as an innovative medical technology.

What Makes Cytotron Distinctive?

Cytotron has been meticulously designed to enhance comfort, usability, and safety. Its architecture guarantees that patients of all ages can receive treatment with a high level of compliance. For healthcare professionals, its functionality integrates effortlessly into standard clinical practices, bolstered by clear imaging-based planning and accurate software-driven delivery.

Scientific References

  • Kumar, R., et al. (2016). Quantum Magnetic Resonance Therapy: Targeting biophysical cancer vulnerabilities to effectively treat and palliate. Journal of Clinical & Experimental Oncology, 5(2), 156.

  • Rajah Vijay Kumar, Kumar R et.al. ICT-2011-088 Integrative Cancer Therapies, “Rotational Field Quantum Nuclear Magnetic Resonance (RFQMR) Therapy: Emerging Treatment in the Management of Terminally Ill Cancer Patients”.

  • G S Nayar, Rajah Vijay Kumar et.al. Neuro Onvol.2016, doi:10.1093/neuonc/now082.19, RO-19: RFQMR therapy in brain tumors in children and young adults.

  • Meena Augustus, Anjana rani Nair et.al. Cancer Science: Open Access, “Precision Targeting of Cancer Chemotherapy Using Non-Invasive Focused Resonance Nano- Permeabilization (FORN): Enhancing Drug Delivery to Limit Life-Threatening Systemic Toxicities and Eliciting Good Clinical Outcomes”.

  • Rajah Vijay Kumar et.al. Journal of Clinical Oncology (ASCO), https://doi.org/10.1200/jco.2014.32.15_suppl.e14013 “Improving therapeutic outcomes and mitigating drug-induced systemic toxicity using non-invasive, targeted focused resonance nanopermeabilization (FORN)”.

  • Meena Augustus et.al. Cancer Research 2015 (AACR),  https://doi.org/10.1158/1538-7445.AM2015-5535 “Abstract 5535: Non-invasive cellular nano-permeabilization to enhance drug delivery and improve therapeutic outcome in solid tumors: Mitigating the path to destruction”.

  • Surg Cdr LJ Pinto et.al. Ind J Aerospace Med 48(2), 2004 “Rotational field quantum magentic resonance (RFQMR) in treatment of osteoarthritis of the knee joint”.

  • Pillai VK et.al. (2019) doi:10.35248/2157-7013.19.10.292 “Nuclear Magnetic Coupled Fast Radio Burst Induced Upregulation of Hsp70 in Regeneration of Human Chindrocytes- A sham Control Study”.

Accreditations & Recognition

Savitur Healthcare is proud to be at the forefront of recognized medical innovation with Cytotron.

Our flagship therapy, CYTOTRON®, has earned:

The U.S. FDA granted Breakthrough Device Designation in 2019 for liver, pancreatic, and
breast cancers.
Approved by CDSCO, Ministry of Health and Family Welfare in 2022.
Internationally, CYTOTRON® is receiving approvals and is being utilized in various countries, establishing it as a revolutionary technology in the global battle against cancer and degenerative diseases.

These accolades underscore not only the scientific validity of our efforts but also our dedication
to delivering advanced therapies to patients around the globe.

Scroll to Top